Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-21

Clinical Trial Update: Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluated hydrocortisone for treating systemic hypotension during hypothermia in asphyxiated newborns with hypoxic-ischemic encephalopat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Semmelweis University | Conditions: Hypoxic-Ischemic Encephalopathy, Asphyxia | Phase 2, Phase 3 | Status: COMPLETED